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ABSTRACT  
The eyes are one of the most sensitive and vulnerable organs in the body. 
Airborne infections, U. V. rays, pollutants, dust and other particles can land 
directly on the surface of the eye, causing eye diseases. Arma, is a disease of 
eye which is characterized by wing like encroachment of the conjunctiva 
over the cornea2 The causative factors of Arma include exposure to dust, 
light, Dhooma, Raja, variation in seasons, unhygienic conditions and Asatmya 
Vihara. Pterygium is common in both developed and developing countries. It 
affects all age groups and both sexes. It is the common cause of ocular 
morbidity. It is a major public health concern in the rural areas of 
developing countries. Arma that is Ptrygium is the disorder in which a thin 
membrane grown from white of the eye having blood like luster and 
bluish. It grows over Krishnamandala that is cornea it not only cosmetically 
disfigures the eye and face but also cause visual disturbance. Arma is 
managed by Lekhana Anjana when it is in its early stage. Sushruta also 
explained a surgical procedure for the management of Arma when it is not 
treated in its early stage and causes complication. The Arma which is in 
early stage and having thin membrane and curd like coloured can be treated 
by Netra Kriyakalpa like Anjana. When the wing like growth encroached to 
the Krishnamandala then it is surgically removed. Here a systematic effort is 
carried out to establish the efficacy of Guduchyadi Rasakriyanjana in the 
management of Arma (Pterygium) to add a drop in the ocean of the 
research.
INTRODUCTION 
 Ayurveda is one among the ancient medical 
science which has given this world a thought to live. 
The principals of Ayurveda have made the world to 
believe it. 
 Ayurveda not only explains about how to 
maintain the health but also explained above diseases 
and their treatment.  
 Shalakya tantra is one of the Ashtangas of 
Ayurveda deals with the diseases affecting the 
Urdhwajatugata Vyadhies (organs above the clavicle). 
The most important organ of Urdhwajatrugata avayawa 
is eye. Dristi Visharada1 (one who is well versed in eye) 
is considered as Shalaki. (Shalakya specialist) 
 Eyes are the only organ by which one can see 
the beauty of nature. The cascade of beautiful and 
healthy eyes mesmerizes every one and every one longs 
it. Eyes are the crowning glory of any person and it is an 
element vital for beauty.  
 The eyes are one of the most sensitive and 
vulnerable organs in the body. Airborne infections, U. V. 
rays, pollutants, dust and other particles can land 
directly on the surface of the eye, causing eye diseases. 
 Sushruta mentioned eleven types of Shuklagata 
Rogas that is the white part of the eye in which Arma is 
also one of the Shuklagata Vyadhies. 
 Arma, is a disease of eye which is characterized 
by wing like encroachment of the conjunctiva over the 
cornea2 The causative factors of Arma include exposure 
to dust, light, Dhooma, Raja, variation in seasons, 
unhygienic conditions and Asatmya Vihara. 
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 Pterygium is common in both developed and 
developing countries. It affects all age groups and both 
sexes. It is the common cause of ocular morbidity. It is a 
major public health concern in the rural areas of 
developing countries. 
 Arma that is Ptrygium is the disorder in which 
a thin membrane grown from white of the eye having 
blood like luster and bluish. It grows over 
Krishnamandala that is cornea it not only cosmetically 
disfigures the eye and face but also cause visual 
disturbance. 
 The Arma which is in early stage and having 
thin membrane and curd like coloured can be treated 
by Netra Kriyakalpa like Anjana. When the wing like 
growth encroached to the Krishnamandala then it is 
surgically removed.  
 In Ayurveda Snehana, Mridu Svedana, 
Siravyadhana, Shiro Virechana, Virechana and Netra 
Kriyakalpas like Anjana, Lepa are mentioned in the 
treatment of Arma3. Out of these Anjana is a simple 
procedure, which is indicated in the initial stage of 
Arma.  
 In classics we get various references regarding 
the use of Guduchi, Haridra, Madhu, Saindhava in 
different forms for Netra Vikaras and in Arma. All these 
drugs are Chakshushya dravya, having Katu, Tikta, 
Kashaya Rasa Laghu, Ruksha Guna and Tridoshgna and 
Rasayana property. These drugs having Anti 
inflammatory, Anti bacterial, Anti oxidant properties.  
 Rasayana property increases the host defiance 
mechanism and the Tridoshagna property pacifies the 
dust Dosha, Dhatu and Mala Vaishmya. Hence the drug 
Guduchyadi Rasakriyanjana is selected for this study. 
 Many types of Anjanas are explained by 
Sushruta, Vagbhata, Bhavaprakasha, Yogaratnakara, 
Vangasena and Chakradutta for the management of 
Arma. 
 Arma is managed by Lekhana Anjana when it is 
in its early stage21. 
 Sushruta also explained a surgical procedure 
for the management of Arma when it is not treated in 
its early stage and causes complication.  
 Sharangadhara explain Guduchyadi 
Rasakriyanjana in Uttarakhanda4 he has explain many 
Yogas for the management of Arma in which ingredient 
of this drug are easily available and cheaper and easily 
prepared. This drug is having good absorption due to 
its method of preparation and its ingredients Madhu 
and Saindhava  
 In the present clinical study twenty patients 
are divided into 2 groups with 15 patients in each 
group. In ‘GRA group’ is administered with Guduchyadi 
Rasakriyanjana; and in ‘MA group’ Anjana with Madhu 
was done to evaluate the effect of Guduchyadi 
Rasakriyanjana in the management of Arma 
(Pterygium). 
Here a systematic effort is carried out to establish the 
efficacy of Guduchyadi Rasakriyanjana in the 
management of Arma (Pterygium) to add a drop in the 
ocean of the research. In this venture, it is sincerely 
hoped that the present study will be a positive step in 
providing an Ayurvedic solution to a burning problem, 
and will be a valuable contribution to the scientific 
world. 
 The entire study contains review of literature, 
which has the literary aspects of Ayurvedic and 
contemporary science. It deals Nirukti, 
Nidanapanchaka, Sadyasadhyata, Chikitsa, review of 
Anjana and drug review. The chapters concerning the 
clinical trials are methodology, observations and 
results, discussion, conclusion, summary and 
bibliography. 
OBJECTIVES OF THE STUDY 
 Shalakya tantra is an important branch of 
Ayurveda since it deals with the treatment of the 
diseases of the Urdhwanga. Netra is the most important 
Dnyanendriya. Acharyas quote “Srvendriyanam 
Nayanam Pradhanum” wise men should always remain 
attentive to save the eyesight so long as they live, as 
days and nights are same; life and wealth are of no use 
for a blind5. 
 Arma, a Suklagata Netra Roga is characterized 
by triangular growth of the Dushit Mamsa Dhatu 
towards the Krishna Mandala, photophobia and itching 
in eyes, inflammation of the tissue and progression of 
the growth leads to refractive error and cosmetic 
deformity.  
 Sushrutacharya explained Arma as a Chedan 
sadhya Vyadhi. Acharya Susruta has cautioned that 
surgery is the first option, if the growth of the tissue 
encroaches the cornea if it is like thick skin Snayu and 
Mamsaja Arma. In the early stage and thin type of Arma 
Lekhan therapy is indicated. Lekhan can be done by 
using Lekhan Anjanas. Hence present study is aimed to 
establish an appropriate therapy which is less irritative 
to the eyes, relieve pain and discomfort; and to 
minimize the growth of the Mamsa Dhatu5.  
 Keeping these goals in mind, in present study, 
Guduchyadi Rasakriyanjana in the management of Arma 
(Pterygium), which is cost effective, more potent, less 
irritant, sterile form of drug having homogenous 
concentration and capable of eliminating the Dooshita 
Dohas and reducing the Lakshanas is selected. 
Objectives of the present study are 
 To evaluate the efficacy of Guduchyadi 
Rasakriyanjana in the management of Arma 
(Pterygium). 
 To evaluate the efficacy of Anjana done with 
honey in the management of Arma (Pterygium). 
 To compare the effects of Anjana with Guduchyadi 
Rasakriyanjana and Honey in the management of 
Arma (Pterygium). 
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METHODOLOGY 
 Research is defined as a scientific study to 
establish the facts by discarding the old or modifying 
them. Many times research is done to validate old 
principles with fresh proofs.  
 Arma is one of the Shuklagata Netraroga, a 
Chedan Sadhya Vyadhi, characterized by triangular 
growth of the fibrovascular tissue of subconjuncta.  
 In Ayurveda different local and systemic 
treatment principals are explained in the management 
of Arma among them Anjana therapy is having utmost 
importance. Hence in this present clinical study 
Guduchyadi Rasakriyanjana (Lekhana Anjana) is 
selected to treat Arma. 
 Rasakriyanjana for the comparative 
assessment of the research work Madhu (Honey) is 
applied as Anjana for another group  
AIMS AND OBJECTIVES OF THE STUDY 
1. To evaluate the efficacy of Guduchyadi 
Rasakriyanjana in the management of Arma 
(Pterygium). 
2. To evaluate the efficacy of Anjana with Honey in 
the management of Arma (Pterygium). 
3. To compare the effects of Guduchyadi 
Rasakriyanjana and Madhu (Honey) in the 
management of Arma (Pterygium). 
MATERIALS AND METHODS 
 The patients of Arma attending the O.P.D and 
I.P.D of Shalakya tantra, S.D.M. Ayurvedic College and 
Hospital, Hassan were selected for this study 
irrespective of their sex, caste and socio economical 
status. The patients were examined in detail as per 
special proforma which includes both Ayurvedic and 
modern methods of examining the patients prepared 
for this purpose. They were further subjected to 
following criteria of inclusion and exclusion and 
investigations for the final diagnosis.  
CRITERIA FOR SELECTION OF PATIENTS  
Inclusion Criteria 
 Patients between the age group of 10 to 60 years 
will be selected irrespective of age, sex, occupation, 
and religion and socio economic status. 
 Patients having the classical Lakshanas of Arma will 
be selected. 
 Duration of disease less than one year. 
 Arma present only in Sukla Mandalas. 
Exclusion Criteria 
 Duration of disease is more than one year. 
 Arma associated with other ocular complications 
and systemic disorders. 
 Patient’s Anarha for Anjana. 
 Arma spread over Krishna Mandala 
Laboratory investigations 
 Random Blood Sugar 
 C T 
 B T 
SAMPLING METHOD AND RESEARCH DESIGN: 30 
diagnosed patients of Arma were admitted in Shalakya 
ward and randomly divided into 2 groups. i.e. GRA 
Group and MA Groups each comprising of 15 patients. 
Guduchyadi Rasakriyanjana (GRA) group: The patients 
of this group were given by Guduchyadi Rasakriyanjana 
on the affected eye every morning for 15 days. No other 
medicine was given internally and externally 
Madhu Anjana (MA) Group: Patients of this group given 
Anjana with Madhu in the affected eye every morning for 
fifteen days. The routine diet was advised to the patients 
of both the groups during the treatment. 
Following method was adopted for performing of Anjana. 
METHOD OF ASHCHYOTANA KARMA24 
Purvakarma: Anjana was performed in a place having 
sufficient light and devoid of direct blowing winds and 
dust. Patient was asked to lie comfortably in supine 
position on a table and eye is cleaned using sterile cotton 
swab. To avoid the anxiety the procedure was explained 
to them.  
Pradhanakarma: After completion of Purvakarma, the 
patient was asked to relax and maintain the supine 
position on the table. The eye of the patient was opened 
with left hand and Guduchyadi Rasakriyanjana is applied 
with right hand from Kaneenika Sandhi to Apanga Sandhi 
with glass rod. This process was repeated daily morning 
for fifteen days. 
Pashchatkarma: After performing the Anjana Karma, 
patient was asked to close eyes slowly and asked to 
rotate in Guduchyadi Rasakriyanjana 
1. Madhu (Honey) 
2. Guduchyadi Rasakriyanjana  
 The ingredients of Guduchyadi Rasakriyanjana 
are Rasakriya of Guduchi and Haridra Madhu and 
Saindhava. 
Method of preparation of Guduchyadi Rasakriyanjana  
The Kalka of Haridra and Stem of Guduchi are taken and 
made Kashaya of it is prepared by Adding sixteen parts of 
water and reduced into fourth of it then it is filtered with 
a clean cloth. The Kashaya is again boiled in the low flame 
to prepare Rasakriya. The Rasakriya is collected and get 
dried is shade and make in to powder for the usage of 
Anjana. At the time of is used honey and Saindhava are 
added in equal quantity and used as Anjana.  
ASSESSMENT CRITERIA: Assessment was done based 
on relief found in the clinical signs and symptoms in the 
patients. For this purpose main clinical signs and 
symptoms were given with suitable scores according to 
their severity before, during and after treatment.  
GRADATION INDEX 
 To give some objectivity to the symptoms for the 
statistical analysis grading was assigned as shown in 
Table-1. 
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Table 1: Showing Gradation Index 
Subjective parameters 
Vedana 
 
0 – Absent  
1 – occasionally present 
2 – frequently present 
3 – Continuous present 
Daha 0 – Absent 
 1–occasionally present and open eyes easily  
 2 –frequently present but open eyes easily 
 3 –frequently present and open eyes with much difficulty 
Ragata 0 – Absent 
1– Discrete, thin vessels vascular net work limited to Pterygium 
2– prominent vascular net work limited to Pterygium 
3–Congestion involving whole BC and. Cirumcorneal zone 
Shopha 
 
0 – Absent 
1 – Chemosis limited only in the pterygium  
2 – Chemosis involving Pterygium and bulbar conjunctiva  
3 –Extensive chemosis spreading to limbal conjunctiva 
Mamsa Vrddhi on Shuklamandala 
 
0 - Absent 
1 – 1/3 part from the canthus to cornea 
2 – 2/3 part from the canthus to cornea 
3- At near cornea 
Photophobia 0 – Absent 
 1–Sensitivity to bright sun light and other bright stimulus 
 2 – Sensitivity to mild sunlight but comfortable in dim lights 
 3 – Sensitivity to even dim light with inability to open eyes 
Foreign body sensation 0 – Absent  
1 – occasionally present 
2 – frequently present with lacrimation 
3 – Continuous present with lacrimation and congestion 
Blurred Vision 
 
0 – Absent  
1 – occasionally present 
2 – frequently present  
3 – Continuous present 
Objective parameters 
Pictorial presentation before and after treatment 
* PG : Pterygium ** B.C: Bulbar conjunctiva. 
Severity of Arma: For assessing the severity of Kaphaja Abhishyanda in each patient the above adopted scores were 
grouped and assessed as follows.  
Absent  0    0 
Mild   1    1- 8score 
Moderate 2    9- 16 
Severe   3    >17 
Statistical analysis of the result: The results having P value less than < 0.05 is considered as statistically 
significant in this study. 
CRITERIA FOR ASSESSMENT OF OVERALL EFFECTS 
Overall effect of the therapy was assessed in terms of complete remission, marked improvement, moderate 
improvement, and mild improvement and unchanged is observed by adopting the following criteria. 
 Complete remission: 100% relief in Chief complaints and no recurrence during follow up study were 
considered as complete remission. 
 Marked improvement: 75 – 100% improvement in chief complaints is recorded as marked improvement. 
 Moderate improvement: 50 - 75% improvement in chief complaints is recorded as moderate improvement. 
 Mild improvement: 25 - 50% improvement in chief complaints is considered as mild improvement. 
AYUSHDHARA, 2015;2(4):269-281 
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 Unchanged: Less than 25% reduction in chief complaints or recurrence of the symptoms to the similar extent 
of severity is noted as recurrence.  
Follow up study: After the completion of treatment, all the patients were advised to attend the O.P.D for two 
months at regular interval of fifteen days for the follow up study. 
Observations and Results 
Vedana: The symptom of Vedana was recorded according to the gradation index. Data was collected and 
statistically analysed.  
Table 2: Showing the ‘t’ test results in reduction of severity of Vedana in GRA group and MA group after 
treatment and during follow up 
Vedana Mean score Reduction 
 In mean score 
% of reduction 
in mean score 
S.D  
of mean 
S.E  
of mean 
df ‘t’ 
Value 
‘p’ 
Value BT AT 
GRA  AT 1.33 0.20 1.13 84.96 0.74 0.19 14 5.91 <0.001 
FU I 1.33 0.27 1.00 79.69 0.85 0.22 14 4.58 <0.001 
FU2 1.33 0.27 1.00 79.69 0.85 0.22 14 4.58 <0.001 
FU3 1.33 0.27 1.00 79.69 0.85 0.22 14 4.58 <0.001 
MA 
 
AT 1.4 0.93 0.33 33.57 0.49 0.13 14 2.65 <0.02 
FU I 1.4 1.13 0.33 19.28 0.49 0.13 14 2.65 <0.02 
FU2 1.4 1.0 0.40 28.57 0.51 0.13 14 3.06 <0.01 
FU3 1.4 1.13 0.33 19.28 0.51 0.13 14 2.65 <0.02 
In GRA group, the mean reduction of Vedana is, 
 Before and after treatment shows changes from 1.33 to 0.2 showing a reduction of 1.13 (84.96 %) which is 
statistically significant at the level of p <0.001 
 Changes after 30 days follow up is from 1.33 to 0.27 showing a reduction of 1.00 (79.69 %) which is statistically 
significant at the level of p <0.001 
 Changes after 45th day follow up is from 1.33 to 0.27 showing a reduction of 1(79.69 %) which is statistically 
significant at the level of p <0.001 
 Changes after 60th day follow up is from 1.33 to 0.27 showing a reduction of 1(79.69%) which is statistically 
significant at the level of p <0.001 
In MA group, the mean reduction of Vedana is, 
 Before and after treatment shows changes from 1.4 to 0.93 showing a reduction of 0.33 (33.57 %) which is 
statistically insignificant at the level of p <0.02 
 Changes after one month follow up is from 1.4 to 1.13 showing a reduction of 0.33 (19.28 %) which is statistically 
significant at the level of p <0.02 
 Changes after 45th day follow up is from 1.4to 1.00 showing a reduction of 0.4(28.57%) which is statistically 
significant at the level of p <0.01 
 Changes after 2nd month follow up is from 1.4 to 1.13 showing a reduction of 0.33(19.28%) which is statistically 
significant at the level of p <0.02 
DAHA: The symptom of Daha was recorded according to the gradation index. Data was collected and statistically 
analysed.  
Table 3: Showing the ‘t’ test results in reduction of severity of Daha in GRA group and MA group after 
treatment and during follow up 
Daha Mean score Reduction 
 In mean score 
% of reduction 
in mean score 
S.D  
of mean 
S.E  
of mean 
df ‘t’ 
Value 
‘p’ 
Value BT AT 
GRA  AT 0.73 0.2 0.53 72.60 0.64 0.17 14 3.23 <0.01 
FU I 0.73 0.26 0.47 64.38 0.64 0.17 14 2.84 <0.02 
FU2 0.73 0.26 0.47 64.38 0.64 0.17 14 2.84 <0.02 
FU3 0.73 0.13 0.47 82.19 0.64 0.17 14 2.84 <0.02 
MA 
 
AT 0.73 0.53 0.27 27.39 0.46 0.12 14 2.26 <0.05 
FU I 0.73 0.53 0.27 27.39 0.46 0.12 14 2.26 <0.05 
FU2 0.73 0.46 0.33  36.98 0.49 0.13 14 2.65 <0.02 
FU3 0.73 0.53 0.27 27.39 0.46 0.12 14 2.26 <0.05 
 
Shailendra Barhate et al. Role of Guduchyadi Rasakriyanjan in the Management of Arma (Pterygium) 
 AYUSHDHARA | July-August 2015 | Vol 2 | Issue 4  274 
In SPA group, the mean reduction in Daha is,  
 Before and after treatment shows changes from 0.73 to 0.2showing a reduction of 0.53 (72.60%) which is 
statistically significant at the level of p <0.01 
 Changes after one month follow up is from 0.73 to 0.26 showing a reduction of 0.47 (64.38%) which is statistically 
significant at the level of p <0.02 
 Changes after 45th day follow up is from 0.73 to 0.26 showing a reduction of 0.47 (64.38%) which is statistically 
significant at the level of p <0.01 
 Changes after 2nd month follow up is from 0.73 to 0.13 showing a reduction of 0.47 (100%) which is statistically 
significant at the level of p <0.02 
In MA group, the mean reduction in Daha is,  
 Before and after treatment shows changes from 0.73 to 0.53 showing a reduction of 0.27 (27.39 %) which is 
statistically insignificant at the level of p < 0.05 
 Changes after one month follow up is from 0.73 to 0.53 showing a reduction of 0.27 (27.39%) which is statistically 
significant at the level of p <0.05 
 Changes after 45th day follow up is from 0.73 to 0.46 showing a reduction of 0.33 (36.98 %) which is statistically 
significant at the level of p <0.02 
 Changes after 2nd month follow up is from 0.73 to 0.53 showing a reduction of 0.27 (27.39 %) which is statistically 
significant at the level of p <0.05 
RAGATA: The symptom of Ragata was recorded according to the gradation index. Data was collected and statistically 
analysed.  
Table 4: Showing the ‘t’ test results in reduction of severity of Ragata in GRA group and MA group after 
treatment and during follow up 
Ragata Mean score Reduction 
 In mean score 
% of reduction 
in mean score 
S.D  
of mean 
S.E  
of mean 
df ‘t’ 
Value 
‘p’ 
Value BT AT 
GRA  AT 1.26 0.46 0.80 63.49 0.56 0.14 14 5.53 <0.001 
FU I 1.26 0.4 0.80 68.25 0.56 0.14 14 5.53 <0.001 
FU2 1.26 0.6 0.60 52.38 0.63 0.16 14 3.67 <0.005 
FU3 1.26 0.53 0.67 57.14 0.62 0.16 14 4.18 <0.001 
MA 
 
AT 0.93 0.53 0.40 43.01 0.51 0.13 14 3.06 <0.01 
FU I 0.93 0.53 0.40 43.01 0.51 0.13 14 3.06 <0.01 
FU2 0.93 0.6 0.33 35.48 0.49 0.13 14 2.65 <0.025 
FU3 0.93 0.6 0.33 35.48 0.49 0.13 14 2.65 <0.025 
In GRA group, the mean reduction in Ragata is,  
 Before and after treatment shows changes from 1.26 to 0.46showing a reduction of 0.80 (63.49%) which is 
statistically significant at the level of p <0.001 
 Changes after one month of follow up is from 1.26 to 0.4 showing a reduction of 0.80 (68.25%) which is 
statistically significant at the level of p <0.001 
 Changes after 45th day follow up is from 1.26 to 0.6 showing a reduction of 0.60 (52.38%) which is statistically 
significant at the level of p <0.005 
 Changes after 2nd month follow up is from 1.26 to 0.53 showing a reduction of 0.67 (57.14%) which is statistically 
significant at the level of p <0.001 
In MA group, the mean reduction in Ragata is,  
 Before and after treatment shows changes from 0.93 to 0.53 showing a reduction of 0.40 (43.01%) which is 
statistically insignificant at the level of p <0.01 
 Changes after one month follow up is from 0.93to 0.53 showing a reduction of 0.40 (43.01%) which is statistically 
significant at the level of p <0.01 
 Changes after 45th day follow up is from 0.93to 0.6 showing a reduction of 0.33 (35.48%) which is statistically 
significant at the level of p <0.025 
 Changes after 2nd month follow up is from 0.93 to 0.6 showing a reduction of 0.33 (35.48%) which is statistically 
significant at the level of p <0.025 
SHOPHA: The symptom of Shopha was recorded according to the gradation index. Data was collected and statistically 
analysed.  
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Table 5: Showing the ‘t’ test results in reduction of severity of Shopha in GRA group and MA group after 
treatment and during follow up 
Shopha Mean score Reduction 
 In mean score 
% of reduction in 
mean score 
S.D  
of mean 
S.E  
of mean 
df ‘t’ 
Value 
‘p’ 
Value BT AT 
GRA  AT 1.26 0.33 0.93 73.80 0.59 0.15 14 6.09 <0.001 
FU I 1.26 0.4 0.80 73.80 0.56 0.14 14 5.53 <0.001 
FU2 1.26 0.33 0.93 73.80 0.59 0.15 14 6.09 <0.001 
FU3 1.26 0.46 0.80 63.49 0.56 0.14 14 5.53 <0.001 
MA 
 
AT 1.2 0.46 0.53 61.16 0.64 0.17 14 3.23 <0.01 
FU I 1.2 0.46 0.53 61.16 0.64 0.17 14 3.23 <0.01 
FU2 1.2 0.6 0.40 50.00 0.51 0.13 14 3.06 <0.01 
FU3 1.2 0.6 0.40 50.00 0.51 0.13 14 3.06 <0.01 
In GRA group, the mean reduction in Shopha is,  
 Before and after treatment shows changes from 1.26 to 0.33showing a reduction of 0.93 (73.80%) which is 
statistically significant at the level of p <0.001 
 Changes after one month follow up is from 1.26 to 0.4 showing a reduction of 0.80 (73.80%) which is statistically 
significant at the level of p <0.001 
 Changes after 45th day follow up is from 1.26 to 0.33 showing a reduction of 0.93 (73.80%) which is statistically 
significant at the level of p <0.001 
 Changes after 2nd month follow up is from 1.26to 0.46 showing a reduction of 0.80 (63.49%) which is statistically 
significant at the level of p <0.001 
In MA group, the mean reduction in Shopha is,  
 Before and after treatment shows changes from 1.2 to 0.46 showing a reduction of 0.53 (61.16 %) which is 
statistically insignificant at the level of p <0.01 
 Changes after one month follow up is from 1.2 to 0.4 showing a reduction of 0.53 (61.16%) which is statistically 
significant at the level of p <0.01 
 Changes after 45th day follow up is from 1.2 to 0.6 showing a reduction of 0.40(50%) which is statistically 
significant at the level of p <0.01 
 Changes after 2nd month follow up is from 1.2 to 0.6 showing a reduction of 0.40(50 %) which is statistically 
significant at the level of p <0.01 
Mamasa Vriddhi on Shukla Mandala: The symptom of Mamsa Vriddhi on Shukla Mandala was recorded according to 
the gradation index. Data was collected and statistically analysed.  
Table 6: Showing the ‘t’ test results in reduction of severity of Mamsa Vriddhi on Shukla Mandala in GRA group 
and MA group after treatment and during follow up 
Mamsa 
Vriddhi 
Mean score Reduction 
 In mean score 
% of reduction 
in mean score 
S.D  
of mean 
S.E  
of mean 
df ‘t’ 
Value 
‘p’ 
Value BT AT 
GRA  AT 1.62 1.2 0.47 25.92 0.52 0.13 14 3.50 <0.005 
FU I 1.62 1.2 0.53 25.92 0.52 0.13 14 4.00 <0.005 
FU2 1.62 1.2 0.47 25.92 0.52 0.13 14 3.50 <0.005 
FU3 1.62 1.2 0.53 22.22 0.52 0.13 14 4.00 <0.005 
MA 
 
AT 1.86 1.73 0.13 6.98 0.35 0.09 14 1.47 >0.05 
FU I 1.86 1.6 0.20 13.97 0.56 0.14 14 1.38 >0.05 
FU2 1.86 1.66 0.13 10.75 0.35 0.09 14 1.47 >0.05 
FU3 1.86 1.66 0.13 10.75 0.35 0.09 14 1.47 >0.05 
In GRA group, the mean reduction of Mamsa Vriddhi on Shukla mandala is, 
 Before and after treatment shows changes from 1.62 to 1.2 showing a reduction of 0.47 (100%) which is 
statistically significant at the level of p <0.05 
 Changes after one month follow up is from 1.62 to 1.2showing a reduction of 0.53 (100%) which is statistically 
significant at the level of p <0.05 
 Changes after 45th day follow up is from 1.62 to 1.2 showing a reduction of 0.47 (100%) which is statistically 
significant at the level of p <0.05 
 Changes after 2nd month follow up is from 1.62to 1.2 showing a reduction of 0.53 (100%) which is statistically 
significant at the level of p <0.05 
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In MA group, the mean reduction of Mamsa Vriddhi on Shukla Mandala is,  
 Before and after treatment shows changes from 1.86 to 1.73 showing a reduction of 0.13 (6.98 %) which is 
statistically significant at the level of p >0.05 
 Changes after one month follow up is from 1.86 to 1.6 showing a reduction of 0.20 (13.97%) which is statistically 
significant at the level of p >0.05 
 Changes after 45th day follow up is from 1.86 to 1.66 showing a reduction of 0.13 (10.75 %) which is statistically 
significant at the level of p >0.05 
 Changes after 2nd month follow up is from 1.86 to 1.66 showing a reduction of 0.13 (10.75 %) which is statistically 
significant at the level of p >0.05 
PHOTOPHOBIA: The symptom of Photophobia was recorded according to the gradation index. Data was collected 
and statistically analysed.  
Table 7: Showing the ‘t’ test results in reduction of severity of Photophobia in GRA group and MA group after 
treatment and during follow up 
Photophobia Mean score Reduction 
 In mean score 
% of reduction 
in mean score 
S.D  
of mean 
S.E  
of mean 
df ‘t’ 
Value 
‘p’ 
Value BT AT 
GRA  AT 1.2 0.46 0.67 61.66 0.49 0.13 14 5.29 <0.001 
FU I 1.2 0.46 0.57 61.66 0.49 0.13 14 5.29 <0.001 
FU2 1.2 0.53 0.60 55.83 0.51 0.13 14 4.58 <0.001 
FU3 1.2 0.46 0.57 61.66 0.49 0.13 14 5.29 <0.001 
MA 
 
AT 1.13 0.86 0.27 23.89 0.46 0.12 14 2.26 <0.05 
FU I 1.13 0.73 0.40 35.39 0.51 0.13 14 3.06 <0.01 
FU2 1.13 0.8 0.33 29.20 0.49 0.13 14 2.65 <0.02 
FU3 1.13 0.8 0.27 29.20 0.46 0.12 14 2.26 <0.05 
In GRA group, the mean reduction in Photophobia is,  
 Before and after treatment shows changes from 1.2 to 0.46 showing a reduction of 0.67 (61.66.%) which is 
statistically significant at the level of p <0.001 
 Changes after one month follow up is from 1.2 to 0.46 showing a reduction of 0.57 (61.66.%) which is statistically 
significant at the level of p <0.001 
 Changes after 45th day follow up is from 1.2 to 0.53 showing a reduction of 0.60(55.83%) which is statistically 
significant at the level of p <0.001 
 Changes after 2nd month follow up is from 1.2 to 0.46 showing a reduction of 0.57 (61.66 %) which is statistically 
significant at the level of p <0.001 
In MA group, the mean reduction in Photophobia is,  
 Before and after treatment shows changes from 1.13 to 0.86 showing a reduction of 0.27 (23.89 %) which is 
statistically significant at the level of p <0.20 
 Changes after one month follow up is from 1.13 to 0.73 showing a reduction of 0.40 (35.39%) which is statistically 
significant at the level of p <0.001 
 Changes after 45th day month follow up is from 1.13 to 0.8 showing a reduction of 0.33 (29.20 %) which is 
statistically significant at the level of p <0.001 
 Changes after 2nd month follow up is from 1.13 to 0.8 showing a reduction of 0.27 (29.20%) which is statistically 
significant at the level of p <0.001 
Foreign Body Sensation: The symptom of foreign body sensation was recorded according to the gradation index. 
Data was collected and statistically analysed.  
Table 8: Showing  results in the reduction of severity of Foreign body sensation in GRA group and MA group 
after treatment and during follow up 
Foreign body 
sensation 
Mean score Reduction 
 In mean score 
% of reduction 
in mean score 
S.D  
of mean 
S.E  
of mean 
df ‘t’ 
Value 
‘p’ 
Value BT AT 
GRA  AT 1.06 0.26 0.73 75.47 0.59 0.15 14 4.78 <0.001 
FU I 1.06 0.26 0.73 75.47 0.59 0.15 14 4.78 <0.001 
FU2 1.06 0.33 0.60 68.86 0.63 0.16 14 3.67 <0.005 
FU3 1.06 0.40 0.60 62.26 0.63 0.16 14 3.67 <0.005 
MA 
 
AT 1.46 1.20 0.27 17.80 0.46 0.12 14 2.26 <0.05 
FU I 1.46 1.33 0.33 8.90 0.49 0.13 14 2.65 <0.02 
FU2 1.46 1.33 0.33 8.90 0.49 0.13 14 2.65 <0.02 
FU3 1.46 1.26 0.20 13.69 0.41 0.11 14 1.87 >0.05 
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In GRA group, the mean reduction in Foreign body sensation is,  
 Before and after treatment shows changes from 1.06 to 0.26 showing a reduction of 0.73 (75.47 %) which is 
statistically significant at the level of p <0.001 
 Changes after ONE MONTH follow up is from 1.06 to 0.26 showing a reduction of 0.73 (75.47 %) which is 
statistically significant at the level of p <0.001 
 Changes after 45th day follow up is 1.06 to 0.33 showing a reduction of 0.60 (68.86 %) which is statistically 
significant at the level of p <0.005 
 Changes after 2nd month follow up is from 1.06 to 0.40 showing a reduction of 0.60 (62.26 %) which is statistically 
significant at the level of p <0.005 
In MA group, the mean reduction in Photophobia is,  
 Before and after treatment shows changes from 1.46 to 1.20 showing a reduction of 0.27 (17.80%) which is 
statistically significant at the level of p <0.02 
 Changes after one month follow up is from 1.46 to 1.33 showing a reduction of 0.33 (8.90%) which is statistically 
significant at the level of p <0.02 
 Changes after 45th day follow up is from 1.46 to 1.33 showing a reduction of 0.33 (8.90%) which is statistically 
significant at the level of p <0.05 
 Changes after 2nd month follow up is from 1.46 to 1.26 showing a reduction of 0.20 (13.69%) which is statistically 
significant at the level of p >0.05 
BLURRED VISION:  
Table 9: Showing results in the reduction of severity of Blurred Vision in GRA group and MA group after 
treatment and during follow up 
Blurred 
Vision 
Mean score Reduction 
 In mean score 
% of reduction 
in mean score 
S.D  
of mean 
S.E  
of mean 
df ‘t’ 
Value 
‘p’ 
Value BT AT 
GRA  AT 0.73 0.26 0.47 64.38 0.64 0.17 14 2.82 <0.02 
FU I 0.73 0.26 0.47 64.38 0.64 0.17 14 2.82 <0.02 
FU2 0.73 0.33 0.40 54.79 0.63 0.16 14 2.45 <0.05 
FU3 0.73 0.20 0.53 72.60 0.74 0.19 14 2.78 <0.02 
MA 
 
AT 0.73 0.53 0.13 27.39 0.35 0.09 14 1.47 >0.05 
FU I 0.73 0.60 0.07 17.80 0.26 0.07 14 1.00 >0.05 
FU2 0.73 0.40 0.27 45.20 0.59 0.15 14 1.74 >0.05 
FU3 0.73 0.40 0.27 44.20 0.59 0.15 14 0.74 >0.05 
In GRA group, the mean reduction in Blurred vision is,  
 Before and after treatment shows changes from 0.73 to 0.26showing a reduction of 0.47 (64.38%) which is 
statistically significant at the level of p <0.02 
 Changes after one month follow up is from 0.73 to 0.26 showing a reduction of 0.47 (64.38%) which is 
statistically significant at the level of p <0.02 
 Changes after 45th day follow up is 0.73 to 0.33 showing a reduction of 0.40 (72.60%) which is statistically 
significant at the level of p <0.05 
 Changes after 2nd month follow up is from 0.73 to 0.20 showing a reduction of 0.53 (72.60%) which is statistically 
significant at the level of p <0.02 
In MA group, the mean reduction in Photophobia is,  
 Before and after treatment shows changes from 0.73 to 0.53 showing a reduction of 0.13 (27.39%) which is 
statistically significant at the level of p >0.05 
 Changes after one month follow up is from 0.73 to 0.60 showing a reduction of 0.7 (17.80%) which is statistically 
significant at the level of p >0.05 
 Changes after 45th day follow up is from 0.27 to 0.60 showing a reduction of 0.27 (45.20%) which is statistically 
significant at the level of p >0.05 
 Changes after 2nd month follow up is from 0.73 to 0.40 showing a reduction of 0.27 (44.20%) which is statistically 
significant at the level of p >0.05 
Thus in all the above parameters of assessment, the percentage of improvement / relief can be made out as follows. 
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Table 10: Showing the percentage of improvement in the symptoms of Arma in GRA group and in MA group 
after treatment and during follow up (i.e. after 30th days of treatment, 45th day, 2 month) 
Over all % of relief  Group GRA  Group MA 
AT FU - 01 FU -02 FU –03 AT FU - 01 FU -02 FU -03 
Vedana 84.96 80 80 80 33.57 19.28 28.57 19.28 
Daha 81.61 64.38 64.38 82.19 27.39 27.39 36.98 27.39 
Ragata 63.49 68.25 52.38 57.14 43.01 43.01 35.48 35.48 
Shopha 73.80 73.80 73.80 63.49 61.16 61.16 50 50 
Mamsa vrddhi 25.92 25.92 25.92 22.22 06.98 13.97 10.75 10.75 
Photophobia 61.66 61.66 55.83 61.66 23.89 35.39 29.20 29.20 
Foreign body sensation 75.47 75.47 68.86 62.26 17.80 8.90 8.90 13.69 
Blurred vision 64.38 64.38 54.79 72.60 27.39 17.80 45.20 45.20 
Table 11: Showing No of patients (in percentage) having relief in each symptoms after treatment; and at the 
end of 1st, 2nd, 3rd follow ups 
1. Vedana  GRA Group   MA Group 
AT FU2 FU3 FU3 AT FU1 FU2 FU3 
Complete relief 60 60 60 60 20 20 20 20 
Moderate relief 20 20 20 20 6.6 6.6 13.3 6.6 
Mild relief 00 00 00 00 00 00 00 00 
Unchanged 20 20 20 20 73.3 73.3 73.3 73.3 
Not present 00 00 00 00 0 00 00 00 
2. Daha GRA Group   MA Group 
AT FU2 FU3 FU3 AT FU1 FU2 FU3 
Complete relief 53.3 46.6 46.6 46.6 20 20 20 20 
Moderate relief 00 00 00 6.66 6.6 6.6 13.3 6.6 
Mild relief 00 00 00 00 00 00 00 00 
Unchanged 40 40 40 40 40 40 40 40 
Unchanged 6.66 13.3 13.3 6.66 33.3 33.3 26.6 33.3 
3. Ragata GRA Group   MA Group 
AT FU2 FU3 FU3 AT FU1 FU2 FU3 
Complete relief 33.3 40 33.3 33.3 40 40 33.3 33.3 
Moderate relief 40 40 26.66 26.66 00 00 00 00 
Mild relief 00 00 00 00 00 00 00 00 
Unchanged 6.66 00 20 20 33.3 33.3 40 40 
Not present 20 20 20 20 26.6 26.6 26.6 26.6 
4. Shopha GRA Group   MA Group 
AT FU2 FU3 FU3 AT FU1 FU2 FU3 
Complete relief 46.6 46.6 46.6 46.6 40 40 33.3 33.3 
Moderate relief 33.3 26.6 33.33 33.33 13.3 13.3 13.3 13.3 
Mild relief 00 00 00 00 00 00 00 00 
Unchanged 00 00 00 00 26.6 26.6 33.3 33.3 
Not present 20 20 20 20 20 20 20 20 
5. Mamas  
Vriddhi 
GRA Group   MA Group 
AT FU2 FU3 FU3 AT FU1 FU2 FU3 
Complete relief 13.3 13.3 13.3 13.3 00 6.6 00 00 
Moderate relief 33.3 33.3 33.3 46.6 13.3 6.6 13.3 13.3 
Mild relief 00 00 00 00 00 00 00 00 
Unchanged 5303 53.3 53.3 40 86 86 86 86 
Not present 00 00 00 00 00 00 00 00 
6. Photophobia GRA Group   MA Group 
AT FU2 FU3 FU3 AT FU1 FU2 FU3 
Complete relief 33.3 33.3 33.3 33.3 20 13.3 13.3 20 
Moderate relief 33.3 33.3 26.6 26.6 6.6 13.3 13.3 6.6 
Mild relief 00 00 00 00 00 00 00 00 
Unchanged 13.3 13.3 20 20 53.3 40 46.6 46.6 
Not present 20 20 20 20 20 20 20 20 
7. Foreign body  GRA Group   MA Group 
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sensation AT FU2 FU3 FU3 AT FU1 FU2 FU3 
Complete relief 40 40 33.3 33.3 20 20 20 6.6 
Moderate relief 26.6 26.6 20 20 6.6 6.6 6.6 6.6 
Mild relief 00 00 00 00 00 00 00 00 
Unchanged 00 00 13.3 13.3 66.6 60 60 80 
Not present 33.3 33.3 33.3 33.3 6.6 6.6 6.6 6.6 
8. Blurred 
vision 
GRA Group   MA Group 
AT FU2 FU3 FU3 AT FU1 FU2 FU3 
Complete relief 33.3 33.3 26.6 40 13.3 6.6 20 20 
Moderate relief 6.6 6.6 6.6 00 00 00 00 00 
Mild relief 00 00 00 00 00 00 00 00 
Unchanged 20 20 26.6 20 46.6 46.6 46.6 46.6 
Not present 40 40 40 40 40 46.6 33.3 33.3 
Table 12: Showing percentage of improvement in the patients of GRA group and MA group 
Overall improvement / relief GRA Group   MA Group 
AT FU2 FU3 FU3 AT FU1 FU2 FU3 
Complete remission 00 00 00 00 00 00 00 00 
Marked relief 02 01 02 03 00 00 00 00 
Moderate relief 10 13 09 03 02 02 03 01 
Mild relief 03 01 04 03 07 06 10 09 
No relief 00 00 00 00 06 07 02 05 
Table 13: Showing percentage of improvement / relief in the patients of Group A and Group B 
Overall improvement / relief No. of Patients in Group A % No. of Patients in Group B % 
Complete remission 00 00% 00 00% 
Marked relief 02 13.33% 00 00% 
Moderate relief 10 66.66% 02 13.33% 
Mild relief 03 20% 07 46.66% 
Not responding 00 00% 06 40% 
DISCUSSION 
Effect on Vedana: As mentioned earlier Vedana 
present in almost all the patients of both groups. 
After15 day’s treatment. The GRA therapy provided 
highly so significant (P<0.001) relief of 84% in Vedana. 
On the other hand relief in MA group was 33.57% and 
it was not statistically significant (p<0.2). Hence, the 
relief in Vedana was better in Guduchyadi 
Rasakriyanjana group than in Madhu anjana group. It 
was observed that in GRA group the amount of Vedana 
was gradually reducing, but in Ma group, it was 
observed that it is having less effect.  
After 30th and 2nd month no marked changes are seen in 
both groups  
Daha: Daha is seen in only 18 patients in both the 
groups (9+9). After 15 days of treatment, the GRA 
therapy provided significant (P<0.01) relief of 72.60% 
in Daha. Relief in MA group was 27.39% and it was 
statistically insignificant (p<0.5). Hence, the relief in 
Daha was better in Guduchyadi Rasakriyanjana group 
than Madhu Anjana group. 
After 30th and 2nd month of treatment, there is not 
much changes are seen on the patients. 
Ragata: Ragata is seen in all patients of group GRA and 
group MAA. Relief from Ragata after treatment was 
63.49% and 43.01% in group GRA and group MA 
respectively. The P value of both groups GRA and MA 
gives results at the level of p<0.001 and p<0.01 
respectively. It indicates that, both groups have relief in 
Ragata after the treatment. However, in group GRA 
after 15 days of treatment, the relief noted was <0.001 
statistically highly significant, and MA group noted 
relief of <0.01 was statistically significant. Hence, 
Guduchyadi Rasakriyanjana is more effective than 
Madhu Anjana in relieving Ragata. 
Shopha: Shopha is seen in all patients of GRA and MA 
group. Relief from Shopha after treatment was 73.80% 
and 61.16% in GRA group and MA group respectively. It 
indicates that, both groups have relief in Shopha after 
the treatment. However, in group GRA is greater 
amount of significance than that of in MA group. Group 
GRA and group MA having significances <0.001 and 
<0.01 respectively. Both the medicine having effect on 
Shotha but at the significance level GRA group is highly 
significant than the MA group. Hence Guduchyadi 
Rasakriyanjana is more effective than Madhu Anjana. 
Mamsa Vriddhi on Shukla Mandala: Mamsa Vriddhi 
on Shukla Mandala is observed in 100% patients in 
both groups. Relief from Vriddhi after treatment was 
25.92% and 6.98% in group GRA and group MA 
respectively. The P value of both groups, GRA and MA 
given results at the level of p<0.005 and >0.05 are 
respectively It indicates that, both groups had relief in 
Mamsa Vriddhi after the treatment. Based on the 
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percentage of relief in Mamsa Vriddhi, Guduchyadi 
Rasakriyanjana is more effective than Madhu Anjana. 
photophobia: Photophobia is seen in all patients of 
group GRA and all patients of group MA. Relief from 
photophobia after treatment was 61.66% and 23.89% 
in GRA group and MA group respectively (P values at 
the level of <0.011 and <0.05 respectively). The relief in 
photophobia after the treatment noted was highly 
significant in GRA group and insignificant in MA group. 
It is suggests that Guduchyadi Rasakriyanjana is more 
effective than Madhu Anjana. 
Foreign Body Sensation: The GRA therapy provided 
highly significant (P<0.001) relief of 75.47% in foreign 
body sensation. On the other hand, relief in MA group 
was 17.80% and it was also not statistically significant 
(p<0.05). Hence, the relief in was better in Guduchyadi 
Rasakriyanjana group than in Madhu Anjana group. 
Blurred Vision: Relief from Blurred vision after 
treatment was 64.38% and 27.39% in GRA group and 
MA group respectively (P values at the level of <0.02 
and <0.5 respectively). The relief in photophobia after 
the treatment noted was significant in GRA group and 
insignificant in MA group. It is suggests that 
Guduchyadi Rasakriyanjana is more effective than 
Madhu Anjana.  
Overall Effect of the Therapies: Consideration of 
overall effect of therapies after 15 days of treatment on 
15 patients showed that in GRA group complete 
remission was found in no patients, marked 
improvement was found in 02 patients, moderate 10 
patients and mild improvement in 3 patients. In 
patients of MA group 02 patients having moderate 
relief, 6 patients have mild relief and no relief was 
found in 7 patients. In the follow up on 30th, 45th and 
60th day it is observed that in GRA group and MA group 
have no marked change is seen. Hence from the above 
results it may be abstracted that Anjana with 
Guduchyadi Rasakriyanjana provided better overall 
effect to the patients of Arma than Anjana with Madhu. 
Discussion on Compared Effect of Therapy  
Guduchyadi Rasakriyanjana: Anjana with Guduchyadi 
Rasakriyanjana rendered statistically significant relief 
in all the symptoms of Arma. None of the patients were 
remained unchanged in group GRA. But very few 
patients of GRA group were reported to have 
aggravation of some of the symptoms during the course 
of treatment or during the follow up. 
Madhu (Honey) Anjana: Anjana with Madhu had 
provided mild relief after treatment and was 
statistically significant. Most of the Patient shows 
remission of some symptoms, maximum patient shows 
unchanged in this group. On this basis of above results 
it can be inferred that Anjana with Guduchyadi 
Rasakriyanjana provided better overall effect to the 
patients of Arma than Anjana with Madhu. Hence 
Guduchyadi Rasakriyanjana is the better choice of drug 
for Anjana in Arma. 
Probable mode of action of Guduchyadi Rasakriy- 
anjana: Anjana is a Netra Kriya Kalpa where the drug is 
instilled into the eyes. It is effective in Lakshanas like 
Vedana, Ragata, Daha, and Shotha. It has direct action 
on the ocular tissues especially on conjunctiva, so it is 
useful in conjunctival disorders. It flushes out debris 
and unwanted tissue due to its Lekhan property. 
Guduchi having Katu Tikta Rasa, Haridra having Katu 
Tikta Rasa, Madhu having Katu Vipak and Ruksha Guna 
Hence all the above drugs having Katu Tikta Rasa 
Ruksha properties act as Lekhana Kari and Chakshushya 
so capable to Scrape the debris without affecting the 
normal tissue of the eye ball.  
 All the drugs are Rasayana, Brumhana, 
Chakshushya, Tridoshahara, Krimighna, Stroto 
Shodhaka, Shothahara, Shoolahara, hence capable to 
reduce the disease. Based on above present study it can 
be supported the efficacy of Guduchyadi Rasakriyanjana 
in the management of Arma. The above results are 
proved in the present clinical study.  
CONCLUSION 
 Arma the disease of Shuklamandala Vyadhi can be 
correlated to Pterygium as per contemporary 
science. 
 In the present clinical study, 30 patients 
presenting with the features of Arma were studied 
in two different groups containing 15 in each. 
 Guduchyadi Rasakriyanjana has more significant 
effect in pacifying the symptoms of Arma and 
marked reduction in clinical symptoms was well 
appreciated within 15days. 
 Madhu Anjana has less significant effect in the 
reduction of the symptoms and recurrence are 
observed while the follow up hence Guduchyadi 
Rasakriyanjana is proved to be cost effective, less 
irritant, safe and better drug in the management 
of Arma. 
 No Adverse effects of the drug were observed 
during the course of study after administration. 
 Guduchyadi Rasakriyanjana and Madhu both were 
found to have greater effect in relieving the 
symptoms of Shopha (Inflammation), but 
Guduchyadi Rasakriya Anjana was more effective 
than Madhu. 
 Guduchyadi Rasakriyanajana is proved to be cost 
effective, less irritant, safe and better drug for 
Anjana in Arma. 
 Rasayana property of all these drugs helps in 
arresting the further degeneration of the tissue. 
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